SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.
FDA's challenges — such as insufficient staffing — can create inefficiencies in the process and potentially put lives at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback